Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guilin Tang

Showing results (251-260 of 344) with videos related to

Pageof 35
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 5, 2017
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphomaAndrés E Quesada, L Jeffrey Medeiros, Parth A Desai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 9, 2025
A Case of Cryptic CBFB::MYH11 Acute Myeloid Leukemia With Noncanonical Breakpoints Detected by Optical Genome MappingEduardo Edelman Saul, Samuel Urrutia, Hui Yang, et al.
American Journal of Clinical Pathology|April 5, 2017
Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter StudyHeesun J Rogers, Eric D Hsi, Guilin Tang, et al.
American Journal of Hematology|January 25, 2021
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinibPreetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, et al.
Cancer Genetics|January 2, 2022
Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignanciesMing Zhao, L Jeffrey Medeiros, Wei Wang, et al.
Leukemia & Lymphoma|October 31, 2025
Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemiaRoberta S Azevedo, Julie Braish, Georgina Gener-Ricos, et al.
American Journal of Hematology|January 20, 2023
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangementsMaria Siddiqui, Sergej Konoplev, Ghayas Issa, et al.
Cancers|January 21, 2023
3q26.2/<i>MECOM</i> Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic FeaturesZhenya Tang, Wei Wang, Su Yang, et al.
Blood|August 25, 2017
Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatmentGhayas C Issa, Hagop M Kantarjian, Graciela Nogueras Gonzalez, et al.
Radiology|September 2, 2025
Comparison of a Specialized Large Language Model with GPT-4o for CT and MRI Radiology Report SummarizationSunyi Zheng, Nannan Zhao, Jing Wang, et al.
Pageof 35

Showing results (251-260 of 344) with videos related to

Sort By:
Pageof 35
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 5, 2017
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphomaAndrés E Quesada, L Jeffrey Medeiros, Parth A Desai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 9, 2025
A Case of Cryptic CBFB::MYH11 Acute Myeloid Leukemia With Noncanonical Breakpoints Detected by Optical Genome MappingEduardo Edelman Saul, Samuel Urrutia, Hui Yang, et al.
American Journal of Clinical Pathology|April 5, 2017
Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter StudyHeesun J Rogers, Eric D Hsi, Guilin Tang, et al.
American Journal of Hematology|January 25, 2021
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinibPreetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, et al.
Cancer Genetics|January 2, 2022
Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignanciesMing Zhao, L Jeffrey Medeiros, Wei Wang, et al.
Leukemia & Lymphoma|October 31, 2025
Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemiaRoberta S Azevedo, Julie Braish, Georgina Gener-Ricos, et al.
American Journal of Hematology|January 20, 2023
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangementsMaria Siddiqui, Sergej Konoplev, Ghayas Issa, et al.
Cancers|January 21, 2023
3q26.2/<i>MECOM</i> Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic FeaturesZhenya Tang, Wei Wang, Su Yang, et al.
Blood|August 25, 2017
Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatmentGhayas C Issa, Hagop M Kantarjian, Graciela Nogueras Gonzalez, et al.
Radiology|September 2, 2025
Comparison of a Specialized Large Language Model with GPT-4o for CT and MRI Radiology Report SummarizationSunyi Zheng, Nannan Zhao, Jing Wang, et al.
Pageof 35